MAPS is currently seeking $8.6 million for European Medicines Agency (EMA) trials to supplement the data gathered for the FDA, with $397,735 already raised and roughly $8.2 million still to go. MAPS will have a clearer estimate of costs for Phase 3 EMA trials after we completes our negotiations with EMA and each individual European country, probably by early to mid-2019.
In July 2018, MAPS raised $378,000 in new donations and pledges from 917 supporters.
On July 16, MAPS began fundraising for the Zendo Project, a harm reduction program of MAPS, which provides peer support services at festivals and events around the world. We’ve raised over $100,000 including an $8,000 matching grant from the Riverstyx Foundation which has been entirely matched. Our new stretch goal is $130,000. Find out more here.
We extend a special thanks to those who so generously supported MAPS last month:
General Support:
- Ullmann Family Foundation ($20,000)
- Garrett Greenburg ($2,500)
- Mack Fuhrer ($2,500)
- Nathan Markovich ($2,500)
- John H. Buchanan ($2,000)
- Bo Zhao ($1,000)
- James Stewart Campbell ($1,000)
- John B. Stuppin ($1,000)
- Marya Hecht ($1,000)
- Nicholas Chubrich ($1,000)
- Paul Stamets ($1,000)
- Sahajia Sarkisian ($1,000)
- Steven Charles Schlansker ($1,000)
Phase 3 MDMA/PTSD U.S.:
- Rebecca Lambert ($50,000)
- Rockefeller Family Fund ($40,000)
- Michael A. Lambert ($20,000)
Phase 3 MDMA/PTSD Europe:
- Abby Rockefeller ($100,000)
- Anonymous ($30,000)
Phase 2 MDMA/End of Life Anxiety:
- Anonymous ($10,000)
Zendo Project:
- Tim Ferriss ($24,000)
- Anonymous ($15,000)
- Anonymous ($4,193)
- Lucas Jushinski ($2,700)
- Adele Getty & Michael Williams ($2,000)
- Nick Sullivan ($1,547)
- Ethan Devine ($1,000)
- Sir Ivan Wilzig with the Peaceman Foundation ($1,000)
- Tyler Norris ($1,000)
- Nick Sullivan ($1,000)
- Ben Williamson ($1,000)
- Joel Dietz ($1,000)
- Ben & Coy Halper ($1,000)
- Anthony Greenberg ($1,000)
- Bill Fell ($1,000)
- Christoph Schoenfleisch ($1,000)
- Kirsten Kairos ($1,000)
- Ronald A. Mis ($1,000)
- DanceSafe ($700)
MAPS relies on the generosity of individual donors to achieve our mission. Psychedelic science is again being conducted under federal guidelines, but no funding for psychedelic psychotherapy research is yet available from governments or major non-family foundations.
Help us reach our goal to make MDMA a medicine by 2021 by establishing a monthly gift of $10 or more. maps.org/donate
Learn how to include MAPS in your will or estate plans.
Learn more about hosting a Global Psychedelic Dinner to fundraise for MAPS.